{"id":"https://openalex.org/W2020809042","doi":"https://doi.org/10.1136/ejhpharm-2013-000276.254","title":"DSL-011 Efficacy and Safety of Epoetin Zeta in Dialysis Patients","display_name":"DSL-011 Efficacy and Safety of Epoetin Zeta in Dialysis Patients","publication_year":2013,"publication_date":"2013-03-01","ids":{"openalex":"https://openalex.org/W2020809042","doi":"https://doi.org/10.1136/ejhpharm-2013-000276.254","mag":"2020809042"},"language":"en","primary_location":{"id":"doi:10.1136/ejhpharm-2013-000276.254","doi":"https://doi.org/10.1136/ejhpharm-2013-000276.254","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ejhpharm-2013-000276.254","pdf_url":"https://ejhp.bmj.com/content/ejhpharm/20/Suppl_1/A91.1.full.pdf","source":{"id":"https://openalex.org/S3012707348","display_name":"European Journal of Hospital Pharmacy","issn_l":"2047-9956","issn":["2047-9956","2047-9964"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Hospital Pharmacy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020809042"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ejhp.bmj.com/content/ejhpharm/20/Suppl_1/A91.1.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044141508","display_name":"J. Bajraktar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Bajraktar","raw_affiliation_strings":["Institute of nephrology, Hospital Pharmacy, Struga, FYROM","1Institute of nephrology, Hospital Pharmacy, Struga, FYROM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of nephrology, Hospital Pharmacy, Struga, FYROM","institution_ids":[]},{"raw_affiliation_string":"1Institute of nephrology, Hospital Pharmacy, Struga, FYROM","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009632142","display_name":"Biljana Lazarova","orcid":"https://orcid.org/0009-0002-0376-6127","observed_orcids":["https://orcid.org/0009-0002-0376-6127"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Lazarova","raw_affiliation_strings":["Clinical Hospital, Hospital Pharmacy, Stip, FYROM","2Clinical Hospital, Hospital Pharmacy, Stip, FYROM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hospital, Hospital Pharmacy, Stip, FYROM","institution_ids":[]},{"raw_affiliation_string":"2Clinical Hospital, Hospital Pharmacy, Stip, FYROM","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010081313","display_name":"E Najdovska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264942","display_name":"Clinical Hospital \"D-r Trifun Panovski\"","ror":"https://ror.org/03e3n8706","country_code":"MK","type":"healthcare","lineage":["https://openalex.org/I4405264942"]}],"countries":["MK"],"is_corresponding":false,"raw_author_name":"E Najdovska","raw_affiliation_strings":["Clinical Hospital, Hospital Pharmacy, Bitola, FYROM","3Clinical Hospital, Hospital Pharmacy, Bitola, FYROM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hospital, Hospital Pharmacy, Bitola, FYROM","institution_ids":["https://openalex.org/I4405264942"]},{"raw_affiliation_string":"3Clinical Hospital, Hospital Pharmacy, Bitola, FYROM","institution_ids":["https://openalex.org/I4405264942"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048949381","display_name":"L Mihajlova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Mihajlova","raw_affiliation_strings":["Clinical Hospital, Hospital Pharmacy, Stip, FYROM","2Clinical Hospital, Hospital Pharmacy, Stip, FYROM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hospital, Hospital Pharmacy, Stip, FYROM","institution_ids":[]},{"raw_affiliation_string":"2Clinical Hospital, Hospital Pharmacy, Stip, FYROM","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"Suppl 1","first_page":"A91.1","last_page":"A91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9520000219345093},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.8519999980926514},{"id":"https://openalex.org/keywords/dialysis-patients","display_name":"dialysis patients","score":0.8550000190734863},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.9309999942779541},{"id":"https://openalex.org/keywords/iron-supplementation","display_name":"iron supplementation","score":0.753000020980835},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7940000295639038},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.7440000176429749},{"id":"https://openalex.org/keywords/dialyzer-clotting","display_name":"dialyzer clotting","score":0.7870000004768372},{"id":"https://openalex.org/keywords/arteriovenous-fistula-thrombosis","display_name":"arteriovenous fistula thrombosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pure-red-cell-aplasia","display_name":"pure red cell aplasia","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8896690607070923},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.6165185570716858},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5944004058837891},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.5840427279472351},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5061318278312683},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.43911731243133545},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.4293716549873352},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42791491746902466},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4001554250717163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/ejhpharm-2013-000276.254","doi":"https://doi.org/10.1136/ejhpharm-2013-000276.254","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ejhpharm-2013-000276.254","pdf_url":"https://ejhp.bmj.com/content/ejhpharm/20/Suppl_1/A91.1.full.pdf","source":{"id":"https://openalex.org/S3012707348","display_name":"European Journal of Hospital Pharmacy","issn_l":"2047-9956","issn":["2047-9956","2047-9964"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Hospital Pharmacy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/ejhpharm-2013-000276.254","doi":"https://doi.org/10.1136/ejhpharm-2013-000276.254","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ejhpharm-2013-000276.254","pdf_url":"https://ejhp.bmj.com/content/ejhpharm/20/Suppl_1/A91.1.full.pdf","source":{"id":"https://openalex.org/S3012707348","display_name":"European Journal of Hospital Pharmacy","issn_l":"2047-9956","issn":["2047-9956","2047-9964"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Hospital Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2020809042.pdf","grobid_xml":"https://content.openalex.org/works/W2020809042.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W86302019","https://openalex.org/W2065055449","https://openalex.org/W7099990938","https://openalex.org/W2140813176","https://openalex.org/W2038557699","https://openalex.org/W1979224380","https://openalex.org/W2007542250","https://openalex.org/W2070734091","https://openalex.org/W2143215387","https://openalex.org/W2017165606"],"abstract_inverted_index":{"Background":[0],"Anaemia":[1,195],"in":[2,27,59,69,211,241,246,258,282,309,322],"chronic":[3,34],"kidney":[4,35],"disease":[5],"(CKD)":[6],"remains":[7],"one":[8],"of":[9,30,48,80,94,119,170,179,204,262,274,290,332],"the":[10,28,44,49,77,81,117,129,168,189,202,205,214,224,286,327],"predictable":[11],"and":[12,46,63,104,139,160,197,207,252,270,300],"modifiable":[13],"non-traditional":[14],"cardiovascular":[15],"risk":[16],"factors.":[17],"Epoetin":[18,156,293,304],"zeta,":[19],"which":[20],"is":[21,25],"a":[22,91,147,177],"biosimilar":[23,50,155],"product,":[24],"used":[26,171],"treatment":[29],"anaemia":[31,291],"associated":[32],"with":[33,73,154,213,292,324],"disease.":[36],"Purpose":[37],"This":[38,65],"study":[39,66,78,219,328],"was":[40,67,172,183,208,222,257,295,321],"performed":[41],"to":[42,54,101,184,187,209,297],"evaluate":[43],"efficacy":[45],"safety":[47],"product":[51],"epoetin":[52,102,220],"zeta":[53,103,157,221,294,305],"maintain":[55],"stable":[56,308],"haemoglobin":[57,131],"levels":[58,191,229],"dialysis":[60,71,135],"patients.":[61,75],"Materials":[62],"Methods":[64],"conducted":[68],"2":[70,95],"centres":[72],"33":[74,82,150],"Before":[76],"30":[79],"patients":[83,98,151,284,310],"were":[84,99,105,123,142,152,200,240,280],"on":[85,285],"various":[86],"erythropoiesis-stimulating":[87],"agents":[88],"(ESA).":[89],"After":[90],"run-in":[92],"period":[93,178],"months,":[96],"all":[97,313],"switched":[100,311],"followed":[106],"for":[107,227,326],"6":[108,161,180],"months.":[109,181],"The":[110,235,302,316],"initial":[111],"weekly":[112],"doses":[113,306],"as":[114,116],"well":[115],"frequency":[118,169],"use":[120],"per":[121],"week":[122],"kept":[124],"constant":[125],"(1\u20133":[126],"times/week).":[127],"During":[128],"follow-up,":[130],"levels,":[132],"iron":[133,198],"status,":[134],"efficiency,":[136],"body":[137],"weight":[138],"adverse":[140,255,318],"events":[141,319],"monitored":[143],"at":[144,201],"least":[145],"once":[146],"month.":[148],"Results":[149],"treated":[153],"(27":[158],"men":[159],"women);":[162],"average":[163],"age":[164],"59.1":[165],"(28\u201376)":[166],"years;":[167],"1\u20133":[173],"doses/week":[174],"subcutaneously,":[175],"over":[176],"Dosing":[182],"be":[185,210,298],"adjusted":[186],"keep":[188],"Hb":[190,228],"within":[192,223],"10.5\u201312":[193],"g/dl.":[194],"management":[196],"supplementation":[199],"discretion":[203],"investigator":[206],"compliance":[212],"current":[215],"label.":[216],"Throughout":[217],"this":[218],"target":[225],"range":[226],"(10.5\u201311.5":[230],"g/dl":[231],"\u00b1":[232],"0.5":[233],"g/dl).":[234],"main":[236],"AEs":[237],"(adverse":[238],"events)":[239],"1":[242,247,259],"patient":[243,248,260],"hypotension":[244],"(3%),":[245],"in-dialyzer":[249],"clotting":[250],"(3%)":[251],"SAE":[253],"(serious":[254],"event)":[256],"thrombosis":[261],"arteriovenous":[263],"fistula":[264],"(AVF)":[265],"(3%).":[266],"No":[267,330],"anti-epoetin":[268],"antibodies":[269],"no":[271],"clinical":[272],"signs":[273],"pure":[275],"red":[276],"cell":[277],"aplasia":[278],"(PRCA)":[279],"observed":[281,317],"any":[283],"study.":[287],"Conclusions":[288],"Treatment":[289],"shown":[296],"effective":[299],"safe.":[301],"mean":[303],"remained":[307],"from":[312],"pre-study":[314],"ESAs.":[315],"profile":[320],"line":[323],"expectations":[325],"population.":[329],"conflict":[331],"interest.":[333]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2016-06-24T00:00:00"}